A Multi-Center, Open-Label, Pharmacokinetic Drug Interaction Study of Erenumab and a Combined Oral Contraceptive in Healthy Females

BACKGROUND: Erenumab is a human anti-calcitonin gene-related peptide monoclonal antibody developed for migraine prevention. Migraine predominately affects women of childbearing age; thus, it is important to determine potential drug–drug interactions between a common oral contraceptive and drugs used...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yang, Gabriel, Kristin, Wang, Yi, Zhou, Yanchen, Eisele, Osaro, Vutikullird, Apinya, Mikol, Daniel D., Lee, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520319/
https://www.ncbi.nlm.nih.gov/pubmed/30963506
http://dx.doi.org/10.1007/s40263-019-00626-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520319/
https://www.ncbi.nlm.nih.gov/pubmed/30963506
http://dx.doi.org/10.1007/s40263-019-00626-2

Ejemplares similares